SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-024270
Filing Date
2023-07-11
Accepted
2023-07-11 17:25:53
Documents
15
Period of Report
2023-07-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 66758
2 ex10-1.htm EX-10.1 369047
3 ex10-2.htm EX-10.2 115740
4 ex10-3.htm EX-10.3 131901
  Complete submission text file 0001493152-23-024270.txt   994413

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE hils-20230705.xsd EX-101.SCH 3030
6 XBRL LABEL FILE hils-20230705_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE hils-20230705_pre.xml EX-101.PRE 22369
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3417
Mailing Address 245 MAIN STREET SUITE 204 CHESTER NJ 07930
Business Address 1200 ROUTE 22 EAST BRIDGEWATER NJ 08807 302-743-2995
Hillstream BioPharma Inc. (Filer) CIK: 0001861657 (see all company filings)

IRS No.: 842642541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41210 | Film No.: 231082816
SIC: 2834 Pharmaceutical Preparations